4DX Stock Overview
4DMedical Limited operates as a medical technology company in Australia and the United States.
4DMedical Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.44|
|52 Week High||AU$1.41|
|52 Week Low||AU$0.32|
|1 Month Change||-20.72%|
|3 Month Change||-29.03%|
|1 Year Change||-62.87%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-72.33%|
Recent News & Updates
Is 4DMedical (ASX:4DX) In A Good Position To Deliver On Growth Plans?Oct 18
We're Hopeful That 4DMedical (ASX:4DX) Will Use Its Cash WiselyJul 05
We Think 4DMedical (ASX:4DX) Can Afford To Drive Business GrowthJan 27
Here's Why We're Not Too Worried About 4DMedical's (ASX:4DX) Cash Burn SituationJun 05
Is 4DMedical Limited's (ASX:4DX) Shareholder Ownership Skewed Towards Insiders?Feb 20
|4DX||AU Healthcare Services||AU Market|
Return vs Industry: 4DX underperformed the Australian Healthcare Services industry which returned -7.6% over the past year.
Return vs Market: 4DX underperformed the Australian Market which returned -2.2% over the past year.
|4DX Average Weekly Movement||8.4%|
|Healthcare Services Industry Average Movement||10.7%|
|Market Average Movement||8.9%|
|10% most volatile stocks in AU Market||15.9%|
|10% least volatile stocks in AU Market||4.1%|
Stable Share Price: 4DX is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: 4DX's weekly volatility (8%) has been stable over the past year.
About the Company
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator.
4DMedical Limited Fundamentals Summary
|4DX fundamental statistics|
Is 4DX overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|4DX income statement (TTM)|
|Cost of Revenue||AU$773.68k|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.084|
|Net Profit Margin||-2,332.63%|
How did 4DX perform over the long term?See historical performance and comparison